100 Most Popular
You can buy or sell Pfizer and other stocks, options, ETFs, and crypto commission-free!
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. Read More The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
100 Most Popular
Pfizer's Lyrica doesn't meet endpoint in epilepsy study
Pfizer Inc. PFE, +0.07% said late Friday one of its drugs did not meet set goals for the treatment of epilepsy in a late stage clinical trial. Pfizer said a Phase 3 clinical trial showed its drug Lyrica did not significantly reduce seizures in epilepsy patients compared with those given a placebo. Lyrica is already approved by the Food and Drug Administration to treat fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain and pain after shingles. Pfizer shares, which closed up less than 0.1% at $4...
Seeking AlphaMay 22
Pfizer Posts Positive Phase 3 Study In Eczema, Catalysts Remain In Second Half Of 2019
Pfizer (PFE) announced that it had achieved positive top-line results for its phase 3 study using abrocitinib to treat patients with atopic dermatitis.
Expected Jul 30, Pre-Market